Gérard N Bischof, Matthias Brendel, Henryk Barthel, Hendrik Theis, Michael Barbe, Peter Bartenstein, Joseph Claasen, Adrian Danek, Günter Höglinger, Johannes Levin, Ken Marek, Bernd Neumaier, Carla Palleis, Marianne Patt, Michael Rullmann, Dorothee Saur, Matthias L Schroeter, John Seibyl, Mengmeng Song, Andrew Stephens, Osama Sabri, Alexander Drzezga, Thilo van Eimeren
We used a new data-driven methodology to identify a set of reference regions that enhanced the quantification of the SUV ratio of the second-generation tau tracer 2-(2-([18 F]fluoro)pyridin-4-yl)-9H-pyrrolo[2,3-b:4,5-c']dipyridine ([18 F]PI-2620) in a group of patients clinically diagnosed with 4-repeat tauopathy, specifically progressive supranuclear palsy or cortical basal syndrome. The study found that SUV ratios calculated using the identified reference regions (i.e., fusiform gyrus and crus-cerebellum) were significantly associated with symptom severity and disease duration...
April 4, 2024: Journal of Nuclear Medicine